Eli Lilly v. Mylan 2015 FC 125 (de Montigny J; 2,371,684 – tadalafil dosage form – CIALIS) This case confirms the possibility that some actions taken during prosecution can be used to interpret the scope of a claim. Facts The patent in question relates to pharmaceuticals and in particular to dosage regimes. The patent included the following claim: 1. A pharmaceutical unit dosage form comprising about 1 to about 20 mg of a compound having the structural formula: said unit dosage form being suitable for oral administration. Issue A question arose as to whether a maximum daily dosage of 20mg should be considered to beRead More →

On January 21, 2016, the Government of Alberta announced funding for an initiative that supports innovative Alberta businesses to commercialize high-tech made-in-Alberta solutions (press release here). The funding is focused on helping further diversify and strengthen the provincial economy. This funding is available through Alberta Innovates Technology Futures (AITF) which supports innovation within technical industries by investing in local research and entrepreneurial talent. In relation to Intellectual Property Rights, AITF’s Micro-Voucher and Voucher scheme can be used to help fund intellectual property assessments and patent development. At Hicks IP, we have been approved as Service Providers for AITF funding and we are experienced in workingRead More →